IPO Note : Global Health International Ltd By Swastika Investmart
Incorporated in 2004, Global Health Limited is one of the largest private multi-speciality tertiary care providers operating in the North and East regions of India with key specialties of cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopaedics, liver transplant, and kidney and urology. Under the “Medanta” brand, Company has a network of five hospitals currently in operation (Gurugram, Indore, Ranchi, Lucknow and Patna) and one hospital (Noida), which is under construction.
* As at June 30, 2022, the company provide healthcare services in over 30 medical specialties and engage over 1,300 doctors led by experienced department heads and, spanning an area of 4.7 million sq. ft., its operational hospitals have 2,467 installed beds.
* As at March 31, 2020, company had 2,141 installed beds, which grew to 2,467 installed beds as at June 30, 2022, representing a growth of 15.23%
* Global Health Limited's hospital at Gurugram was ranked as the best private hospital in India for three consecutive years in 2020, 2021 and 2022, and was the only Indian private hospital to be featured in the list of top 200 global hospitals in 2021 and was featured in the list of top 250 global hospitals in 2022 by Newsweek.
* In Fiscals 2020, 2021 and 2022 and the three months ended June 30, 2021 and 2022, It generated income from healthcare services of ?14,805.71 million, ?14,178.41 million, ?21,003.95 million, ?4,732.10 million and ?5,960.89 226 million, respectively, and had EBITDA of ?2,304.54 million, ?2,228.52 million, ?4,897.57 million, ?1,057.69 million and ?1,416.46 million, respectively.
To Read Complete Report & Disclaimer Click Here
Please refer disclaimer at https://www.swastika.co.in/disclaimer
SEBI Reg. No. : NSE/BSE/MSEI: INZ000192732
Views express by all participants are for information & academic purpose only. Kindly read disclaimer before referring below views. Click Here For Disclaimer